[Research Report] The plasma therapy market size is expected to grow from US$ 390.25 million in 2022 to US$ 1,097.64 million by 2030; the market is estimated to register a CAGR of 13.80% from 2022 to 2030.
Analyst’s Viewpoint
The plasma therapy market analysis explains growth drivers such as the rising cases of orthopedic disorders in people, especially in the geriatric population; rising number of joint and muscle injuries in athletes, and surging demand for minimally invasive cosmetic procedures. Further, the customization of plasma therapies according to patients’ needs is expected to introduce new trends in the market during 2022–2030.
Plasma therapy, also termed as platelet-rich plasma (PRP) therapy, entails the utilization of the blood plasma obtained from individuals who have successfully recovered from an illness to address the range of medical conditions and foster the process of healing. PRP treatments find applications in orthopedics for the treatment of joint injuries, dermatology in skin rejuvenation procedures, and dentistry for tissue repair. The growth factors present in PRP effectively stimulate the regeneration of tissues, thereby expediting the healing of injuries or enhancing mechanisms involved in aesthetic procedures.
Market Insights
Rising Cases of Orthopedic Disorders & Muscle Injuries and Increasing Use of PRP in Aesthetic Procedures Fuel Plasma Therapy Market
According to statistics published by the World Health Organization (WHO) in 2023, ~528 million people across the world were living with osteoarthritis (OA) in 2019, representing an increase of 113% since 1990. An article published in PubMed Central in December 2020 states that the use of PRP offers potential for tissue repair due to the abundance of growth factors and cytokines in this plasma, which are crucial in initiating and modulating regenerative microenvironments for both soft and hard tissues. PRP therapy can be used in the healing of bone fractures; ligament, muscle, and tendon injuries; peripheral nerve injuries; articular cartilage lesions; and osteoarthritis. Therefore, there is a high demand for plasma therapies in orthopedic and tissue repair procedures.
Moreover, PRP is used in cosmetic surgeries for skin rejuvenation, anti-aging, and other aesthetic procedures. Out of 73 studies evaluated in a review published in PubMed Central in November 2021, 45 studies focused on PRP monotherapy, while 35 studies investigated the effects of PRP in combination with micro needling. As a result, the therapies were well-tolerated and suitable for all phototypes. Positive treatment outcomes were identified for various conditions, including skin rejuvenation, scar revision, alopecia, pigmentary disorders, lichen scleroses, leprosy-induced peripheral neuropathy, plaque psoriasis, and nail disorders.
Therefore, the use of PRP in cosmetic surgeries contributes to the growth of the plasma therapy market.
Future Trend
Customization Options to Introduce Patient-Centric Therapies Emerge as Future Trend in Plasma Therapy Market
Customized plasma therapy entails personalizing plasma therapies to meet patients’ needs based on factors such as their specific medical conditions and genetic makeup. Customization efforts are focused on improving the efficacy of plasma therapy by tailoring the composition of components such as antibodies and proteins to treat the specific health condition of the patient more effectively. Researchers and healthcare professionals are implementing their expertise to come up with ways to tailor plasma therapy to specific ailments such as autoimmune disorders, infectious diseases, and rare cancer types. Companies such as Regenexx and Bridging Biosciences provide highly pure and concentrated PRP customizable to eliminate inconsistencies for healing of tissue damage and cell regeneration. USA Medical Research Institute in Texas offers PRP TruDose therapy, which contains personalized therapeutic doses for the treatment of various chronic pain for musculoskeletal conditions, LUPUS, food sensitivities, Lyme disease, and many degenerative conditions.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Plasma Therapy Market: Strategic Insights
Market Size Value in US$ 390.25 million in 2022 Market Size Value by US$ 1,097.64 million by 2030 Growth rate CAGR of 13.80% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Plasma Therapy Market: Strategic Insights
| Market Size Value in | US$ 390.25 million in 2022 |
| Market Size Value by | US$ 1,097.64 million by 2030 |
| Growth rate | CAGR of 13.80% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Report Segmentation and Scope
Type-Based Insights
Based on type, the plasma therapy market is segmented into pure PRP, leukocyte-rich PRP, pure platelet-rich fibrin, and leukocyte-rich fibrin. The pure platelet-rich fibrin segment held the largest market share in 2022 and is anticipated to register the highest CAGR during 2022–2030. Leukocyte-rich PRP (LR-PRP) is a type of PRP that has a higher concentration of neutrophils (white blood cells) than the baseline level. It is generally associated with proinflammatory effects. However, in some cases, LR-PRP can be beneficial to stimulate inflammation in the body to indicate a chronic condition such as tendinopathy.
Source-based Insights
The plasma therapy market, based on source, is bifurcated into autologous and allogeneic. The autologous segment dominated the market in 2020.
Application-based Insights
The plasma therapy market, by application, is segmented into orthopedic conditions, dermatology, dental issues, and others. The dermatology segment held the largest market share in 2022.
End User-Based Insights
In terms of end user, the plasma therapy market is categorized as hospitals and clinics, research institutes, ambulatory surgical centers (ASCs), and others. The hospital segment held the largest share of the market in 2022 and is anticipated to register the highest CAGR in the market during 2022–2030.
Plasma Therapy Market Report Scope
Regional Analysis
North America dominated the plasma therapy market in 2022. It is further expected to record the highest CAGR in the market during 2022–2030. The market in North America is segmented into the US, Canada, and Mexico. The US holds the largest market share of the global plasma therapy market. Market growth in the country is attributed to the burgeoning adoption of platelet-rich plasma (PRP) in orthopedic and cosmetic surgeries, rising investments in the healthcare sector, dynamics research and development landscape, and USFDA approval for selected PRP therapies.
The report profiles leading players operating in the global plasma therapy market. These include BioLife Plasma Services; Takeda Pharmaceutical Company Limited; Biotest AG CSL Ltd.; Grifols, S.A.; Kedrion S.p.A; ImmunoTek Bio Centers; Bio Products Laboratory Ltd.; China Biologic Products Holdings, Inc.; Octapharma AG; and Origin, Inc. These leading players focus on expanding and diversifying their market presence and clientele, thereby tapping prevailing business opportunities.
Key Developments by Major Market Players are:
- In March 2023, BioLife Plasma Services announced the opening of its plasma donation center in the US with new locations in West Springfield (Massachusetts) and Pearland (Texas). This expansion would help the company expand its business network.
- In February 2021, Atlas Health Medical Group launched the SkinPen. This small pen-shaped microneedling device containing PRP for facelifts punctures the skin and stimulates an anti-aging response.
- In March 2020, Takeda Pharmaceutical Company Limited initiated the development of an anti-SARS-CoV-2 polyclonal hyperimmune globulin (H-Ig) to treat individuals suffering from severe COVID-19.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Source, Application, End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The plasma therapy market majorly consists of the players such include BioLife Plasma Services; Takeda Pharmaceutical Company Limited; Biotest AG CSL Ltd.; Grifols, S.A.; Kedrion S.p.A; ImmunoTek Bio Centers; Bio Products Laboratory Ltd.; China Biologic Products Holdings, Inc.; Octapharma AG; and Origin, Inc.
Global plasma therapy market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. North America held the largest market share of the plasma therapy market in 2022.
The CAGR value of the plasma therapy market during the forecasted period of 2020-2030 is 13.80%.
Plasma therapy entails the utilization of the blood plasma obtained from individuals who have successfully recovered from an illness to address the range of medical conditions and foster the process of healing. PRP treatments find applications in orthopedics for the treatment of joint injuries, dermatology in skin rejuvenation procedures, and dentistry for tissue repair. The growth factors present in PRP effectively stimulate the regeneration of tissues, thereby expediting the healing of injuries or enhancing mechanisms involved in aesthetic procedures.
The orthopedic conditions segment dominated the global plasma therapy market and held the largest market share of 35.31% in 2022.
The rising cases of orthopedic disorders in people, especially in the geriatric population; rising number of joint and muscle injuries in athletes, and surging demand for minimally invasive cosmetic procedures.
1. Introduction
1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness Analysis
3. Research Methodology
4. Plasma Therapy Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Plasma Therapy Market - Key Market Dynamics
5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints
6. Plasma Therapy Market - Global Market Analysis
6.1 Plasma Therapy - Global Market Overview
6.2 Plasma Therapy - Global Market and Forecast to 2030
7. Plasma Therapy Market – Revenue Analysis (USD Million) – By Type, 2020-2030
7.1 Overview
7.2 Pure PRP
7.3 Leukocyte-Rich PRP
7.4 Pure Platelet-Rich Fibrin
7.5 Leukocyte-Rich Fibrin
8. Plasma Therapy Market – Revenue Analysis (USD Million) – By Source, 2020-2030
8.1 Overview
8.2 Autologous
8.3 Allogenic
9. Plasma Therapy Market – Revenue Analysis (USD Million) – By Application, 2020-2030
9.1 Overview
9.2 Orthopedic
9.3 Dermatology
9.4 Cardiac Muscle Injury
9.5 Dental
9.6 Nerve Injury
9.7 Others
10. Plasma Therapy Market – Revenue Analysis (USD Million) – By End Products Produce , 2020-2030
10.1 Overview
10.2 Albumin
10.3 Immunoglobulin G (IgG)
10.4 Others
11. Plasma Therapy Market – Revenue Analysis (USD Million) – By End User, 2020-2030
11.1 Overview
11.2 Hospitals and Clinics
11.3 Research Institutes
11.4 Ambulatory Surgical Centers
12. Plasma Therapy Market - Revenue Analysis (USD Million), 2020-2030 – Geographical Analysis
12.1 North America
12.1.1 North America Plasma Therapy Market Overview
12.1.2 North America Plasma Therapy Market Revenue and Forecasts to 2030
12.1.3 North America Plasma Therapy Market Revenue and Forecasts and Analysis - By Type
12.1.4 North America Plasma Therapy Market Revenue and Forecasts and Analysis - By Source
12.1.5 North America Plasma Therapy Market Revenue and Forecasts and Analysis - By Application
12.1.6 North America Plasma Therapy Market Revenue and Forecasts and Analysis - By End Products Produce
12.1.7 North America Plasma Therapy Market Revenue and Forecasts and Analysis - By End User
12.1.8 North America Plasma Therapy Market Revenue and Forecasts and Analysis - By Countries
12.1.8.1 United States Plasma Therapy Market
12.1.8.1.1 United States Plasma Therapy Market, by Type
12.1.8.1.2 United States Plasma Therapy Market, by Source
12.1.8.1.3 United States Plasma Therapy Market, by Application
12.1.8.1.4 United States Plasma Therapy Market, by End Products Produce
12.1.8.1.5 United States Plasma Therapy Market, by End User
12.1.8.2 Canada Plasma Therapy Market
12.1.8.2.1 Canada Plasma Therapy Market, by Type
12.1.8.2.2 Canada Plasma Therapy Market, by Source
12.1.8.2.3 Canada Plasma Therapy Market, by Application
12.1.8.2.4 Canada Plasma Therapy Market, by End Products Produce
12.1.8.2.5 Canada Plasma Therapy Market, by End User
12.1.8.3 Mexico Plasma Therapy Market
12.1.8.3.1 Mexico Plasma Therapy Market, by Type
12.1.8.3.2 Mexico Plasma Therapy Market, by Source
12.1.8.3.3 Mexico Plasma Therapy Market, by Application
12.1.8.3.4 Mexico Plasma Therapy Market, by End Products Produce
12.1.8.3.5 Mexico Plasma Therapy Market, by End User
Note - Similar analysis would be provided for below mentioned regions/countries
12.2 Europe
12.2.1 Germany
12.2.2 France
12.2.3 Italy
12.2.4 Spain
12.2.5 United Kingdom
12.2.6 Rest of Europe
12.3 Asia-Pacific
12.3.1 Australia
12.3.2 China
12.3.3 India
12.3.4 Japan
12.3.5 South Korea
12.3.6 Rest of Asia-Pacific
12.4 Middle East and Africa
12.4.1 South Africa
12.4.2 Saudi Arabia
12.4.3 U.A.E
12.4.4 Rest of Middle East and Africa
12.5 South and Central America
12.5.1 Brazil
12.5.2 Argentina
12.5.3 Rest of South and Central America
13. Industry Landscape
13.1 Mergers and Acquisitions
13.2 Agreements, Collaborations, Joint Ventures
13.3 New Product Launches
13.4 Expansions and Other Strategic Developments
14. Competitive Landscape
14.1 Heat Map Analysis by Key Players
14.2 Company Positioning and Concentration
15. Plasma Therapy Market - Key Company Profiles
15.1 BioLife Plasma Services
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
Note - Similar information would be provided for below list of companies
15.2 Takeda Pharmaceutical Company Limited
15.3 Biotest AG
15.4 CSL Ltd.
15.5 Grifols, S.A.
15.6 Kedrion S.p.A
15.7 ImmunoTek Bio Centers
15.8 Bio Products Laboratory Ltd.
15.9 China Biologic Products Holdings, Inc.
15.10 Octapharma AG
15.11 Origin, Inc.
16. Appendix
16.1 Glossary
16.2 About The Insight Partners
16.3 Market Intelligence Cloud
The List of Companies - Plasma Therapy Market
- Biotest
- CSL Ltd.
- Grifols
- Kedrion S.p.A
- China Biologics, Inc.
- Octapharma
- Cambrin Biologics
- LFB SA
- Biolife Plasma Services
- China Biologics Products
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Plasma Therapy Market
Nov 2023
Laser-Assisted ENT Surgeries Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Laser Type (C02 Laser, Nd:YAG Laser, Diode Laser, Blue Laser, KTP Laser, Argon Laser, and Other Laser Types), Surgery Type [Laser Laryngeal Surgery, Laser Endoscopic Sinus Surgery (LESS), Laser-Assisted Uvulopalatoplasty (LAUP), Laser-Assisted Stapedotomy, Laser-Assisted Tonsillectomy and Adenoidectomy, Laser Turbinates Reduction, Transoral Laser Microsurgery (TLM), Nasal Surgery, and Other Surgery Types], End User (Hospitals and Specialty Clinics, Physician Offices, and Other End Users), and Geography (North America, Europe, Asia Pacific, South and Central America, and Middle East and Africa)
Nov 2023
Mobile Cleanroom Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Softwall and Hardwall), End User (Microelectronics Industry, Pharmaceuticals and Biotechnology Industry, Medical Device Manufacturers, and Others), and Geography
Nov 2023
Ovo-Sexing Technology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technique (Non-Invasive Imaging, Genetic Editing, Volatile Analysis, Sex Reversal, and Liquid-Based Analysis), End User (Hatcheries and Poultry Farms), and Geography (US, Germany, France, Italy, Spain, Rest of Europe, Israel, and ROW)
Nov 2023
Dental Laser Treatment Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Hard Tissue, Soft Tissue, and Others), End User (Hospitals, Dental Clinics, Dental-Owned Practices, and Others), Clinical Indication [Conservative Dentistry, Root Canal (Endodontic Treatment), Oral Surgery, Implantology, Peri-Implantitis, Periodontics, and Others], and Geography
Nov 2023
Microbiology CRO Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Clinical, Medical Device, and Others), Service Type (Assay Development, Custom Viral Stock Production, Microbial Testing, and Others), Microorganisms (Bacteria, Fungi, Viruses, and Parasites), End User (Biotech and Pharmaceutical Companies, Medical Device Companies, and Others), and Geography
Nov 2023
Antimicrobial Surgical Suture Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Triclosan Antimicrobial Suture and Chlorhexidine Antimicrobial Suture), Raw Materials (Polyglactin 910 Antimicrobial Suture, Poliglecaprone 25, and Polyglycolic Acid), Application (Cardiovascular Surgery, General Surgery, Ophthalmic Surgery, Gynecological Surgery, Orthopedic Surgery, Plastic Surgery, Veterinary Surgery, Dental Surgery, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2023
Fall Management Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sensor Pads, Floor Mat, Hip Protectors, Alert Systems, Communication Devices, and Other Products), Application (Fall Detection Systems, Fall Prevention Equipment, and Post-Fall Monitoring and Response Systems), Age Group [Elderly Population (65 and Above) and Adults (18–64 years)], End User (Hospitals and Clinics, Nursing Homes, Home Care Settings, and Other End Users), and Geography
Nov 2023
Organoids Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Get Free Sample For